Tool-Augmented AI for Drug Discovery: An Agentic Platform for Integrated Molecule Generation and Screening
- Leili Zhang
- Bc Kwon
- et al.
- 2026
- ACS Spring 2026
Talk
Elif Eyigoz
Title
Staff Research Scientist
Bio
Elif Eyigoz has a multi-disciplinary background with degrees in Philosophy (BA), Statistics (MA), Cognitive Science (MA), Linguistics (MA), and Computer Science (MS and PhD). After she completed her PhD in Computer Science, she joined IBM as a natural language processing (NLP) algorithms developer, and later joined IBM as a researcher. Her current research interests include disease progression modeling, drug discovery, and applications of NLP in healthcare.
Publications
Designing Agentic AI Systems for Human-Guided Scientific Discovery in Computational Drug Discovery
- Bc Kwon
- Leili Zhang
- et al.
- 2026
- ACS Spring 2026
PosterTowards accelerating small molecule drug discovery with pre-trained, late fusion multi-view models
- Joseph Morrone
- Diwakar Mahajan
- et al.
- 2024
- ACS Fall 2024
TalkDPM360: New Additions to Advanced Disease Progression Modeling
- Akira Koseki
- Italo Buleje
- et al.
- 2022
- OHDSI Collaborator Showcase 2022
Poster
Top collaborators
JH
Jianying Hu
IBM Fellow; Director HCLS Research; Global Sci. Leader AI for Health; Exec. Partner for Cleveland Clinic
CT
Ching-Huei Tsou
Senior Research Scientist & Manager, Biomedical Foundation Model / NLP | Accelerated Discovery | HCLS
PS
Partha Suryanarayanan
Senior Research Scientist
JM
Joseph Morrone
Research Staff Member - Healthcare & Life Sciences Research